Quanterix Corporation Capital Expenditures Incurred but Not yet Paid
Quanterix Corporation (QTRX) reported Capital Expenditures Incurred but Not yet Paid of $419.00 thousand for the 12-month period ending 2023-12-31, per its 10-K/A filed 2024-12-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2024-12-26
- Quanterix Corporation capital expenditures incurred but not yet paid for the quarter ending 2023-03-31 was $147.00K.
- Quanterix Corporation capital expenditures incurred but not yet paid for the quarter ending 2022-12-31 was -$136.00K.
- Quanterix Corporation capital expenditures incurred but not yet paid for the quarter ending 2021-12-31 was -$77.00K, a 111.48% decline year-over-year.
- Quanterix Corporation capital expenditures incurred but not yet paid for the quarter ending 2021-09-30 was -$583.00K, a 280.50% decline year-over-year.
- Quanterix Corporation capital expenditures incurred but not yet paid for fiscal 2023 was $419.00K, a 175.66% increase from fiscal 2022.
- Quanterix Corporation capital expenditures incurred but not yet paid for fiscal 2022 was $152.00K, a 33.62% decline from fiscal 2021.
- Quanterix Corporation capital expenditures incurred but not yet paid for fiscal 2021 was $229.00K, a 77.75% decline from fiscal 2020.
- Quanterix Corporation capital expenditures incurred but not yet paid for fiscal 2020 was $1.03M, a 527.44% increase from fiscal 2019.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 9 month as first filed | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $419.00K 10-K/A · filed 2024-12-26 | ||||
| 2023-03-31 | $147.00K 10-K/A · filed 2024-12-26 | $11.00K derived: sum of 2 quarters · filed 2024-12-26 | |||
| 2022-12-31 | -$136.00K derived: 10-K/A 12 month − 10-K/A 9 month · filed 2024-12-26 | $152.00K 10-K/A · filed 2024-12-26 | |||
| 2022-09-30 | $288.00K 10-K/A · filed 2024-12-26 | $198.00K 10-Q · filed 2022-11-09 | |||
| 2021-12-31 | -$77.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | -$660.00K derived: sum of 2 quarters · filed 2024-12-26 | -$3.11M derived: sum of 3 quarters · filed 2024-12-26 | $229.00K 10-K/A · filed 2024-12-26 | |
| 2021-09-30 | -$583.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$3.04M derived: sum of 2 quarters · filed 2022-11-09 | $306.00K 10-Q · filed 2022-11-09 | $977.00K derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-06-30 | -$2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $889.00K 10-Q · filed 2021-08-05 | $1.56M derived: sum of 3 quarters · filed 2023-03-06 | $1.88M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-03-31 | $3.34M 10-Q · filed 2021-05-06 | $4.01M derived: sum of 2 quarters · filed 2023-03-06 | $4.33M derived: sum of 3 quarters · filed 2023-03-06 | $4.27M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2020-12-31 | $671.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $994.00K derived: sum of 2 quarters · filed 2023-03-06 | $927.00K derived: sum of 3 quarters · filed 2023-03-06 | $1.03M 10-K · filed 2023-03-06 | |
| 2020-09-30 | $323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $256.00K derived: sum of 2 quarters · filed 2021-11-04 | $358.00K 10-Q · filed 2021-11-04 | $477.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $35.00K 10-Q · filed 2021-08-05 | $154.00K derived: sum of 3 quarters · filed 2022-03-01 | -$80.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $102.00K 10-Q · filed 2021-05-06 | $221.00K derived: sum of 2 quarters · filed 2022-03-01 | -$13.00K derived: sum of 3 quarters · filed 2022-03-01 | $255.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$115.00K derived: sum of 2 quarters · filed 2022-03-01 | $153.00K derived: sum of 3 quarters · filed 2022-03-01 | $164.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $34.00K derived: sum of 2 quarters · filed 2020-11-06 | $45.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $268.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $279.00K 10-Q · filed 2020-08-04 | |||
| 2019-03-31 | $11.00K 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | $78.00K 10-K · filed 2021-03-05 | ||||
| 2018-06-30 | $29.00K 10-Q · filed 2019-08-06 | ||||
| 2017-12-31 | -$203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$12.00K derived: sum of 2 quarters · filed 2019-03-18 | -$5.00K derived: sum of 3 quarters · filed 2019-03-18 | $74.00K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $198.00K derived: sum of 2 quarters · filed 2018-11-07 | $277.00K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $86.00K 10-Q · filed 2018-08-10 | |||
| 2017-03-31 | $79.00K 10-Q · filed 2018-05-15 | ||||
| 2016-12-31 | $72.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |